| 2016-12 | Circulating leptin level in rheumatoid arthritis and its correlation with disease activity: a meta-analysis | 배상철 |
| 2017-10 | Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis | 배상철 |
| 2017-06 | Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus | 배상철 |
| 2018-06 | Clinical characteristics of multifocal osteonecrosis in Korean patients with rheumatic disease | 배상철 |
| 2019-05 | Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values | 배상철 |
| 2013-06 | CLINICAL PREDICTORS OF PREGNANCY OUTCOMES AND PREMATURE MENOPAUSE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | 배상철 |
| 2015-11 | Clinical validation of surface-enhanced Raman scattering-based immunoassays in the early diagnosis of rheumatoid arthritis | 배상철 |
| 2018-10 | Coffee consumption and the risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization study | 배상철 |
| 2014-10 | Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis | 배상철 |
| 2017-06 | Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritis | 배상철 |
| 2018-05 | Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis A Bayesian network meta-analysis of randomized controlled trials | 배상철 |
| 2018-05 | Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 배상철 |
| 2019-04 | Comparative efficacy and safety of biosimilar rituximab and originator rituximab in combination with methotrexate in patients with active rheumatoid arthritis: A Bayesian network meta-analysis | 배상철 |
| 2018-05 | Comparative efficacy and safety of biosimilar-infliximab and originator-infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta-analysis of randomized controlled trials | 배상철 |
| 2019-06 | Comparative efficacy and safety of low-dose and high-dose cyclophosphamide as induction therapy for lupus nephritis: a network meta-analysis | 배상철 |
| 2018-06 | Comparative efficacy and safety of TNF-inhibitor plus methotrexate versus oral triple therapy in patients with active rheumatoid arthritis inadequately responding to methotrexate: A meta-analysis of randomized controlled trials | 배상철 |
| 2016-11 | Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials | 배상철 |
| 2015-12 | Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 배상철 |
| 2018-02 | Comparative efficacy and tolerability of monotherapy with leflunomide or tacrolimus for the treatment of rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials | 배상철 |
| 2018-06 | Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis A Bayesian network meta-analysis of randomized controlled trials | 배상철 |
